Certior Financial Group LLC Invests $236,000 in Cibus, Inc. (NASDAQ:CBUS)

Certior Financial Group LLC acquired a new stake in Cibus, Inc. (NASDAQ:CBUS) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 84,985 shares of the company’s stock, valued at approximately $236,000. Certior Financial Group LLC owned 0.32% of Cibus as of its most recent SEC filing.

Several other large investors have also bought and sold shares of CBUS. Geode Capital Management LLC lifted its holdings in Cibus by 7.5% in the 4th quarter. Geode Capital Management LLC now owns 392,387 shares of the company’s stock valued at $1,091,000 after acquiring an additional 27,464 shares during the last quarter. Sei Investments Co. acquired a new stake in Cibus during the fourth quarter valued at approximately $49,000. Commonwealth Equity Services LLC bought a new stake in Cibus during the fourth quarter worth approximately $62,000. Raymond James Financial Inc. bought a new stake in Cibus during the fourth quarter worth approximately $89,000. Finally, IFP Advisors Inc acquired a new position in Cibus in the fourth quarter worth approximately $36,000. Institutional investors own 33.81% of the company’s stock.

Cibus Stock Performance

Shares of NASDAQ:CBUS opened at $1.52 on Monday. Cibus, Inc. has a 52 week low of $1.50 and a 52 week high of $21.24. The company has a market cap of $49.93 million, a PE ratio of -0.07 and a beta of 1.83. The firm has a 50 day simple moving average of $2.21 and a 200 day simple moving average of $3.11.

Cibus (NASDAQ:CBUS) last announced its quarterly earnings data on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing analysts’ consensus estimates of ($0.68) by ($0.19). Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. The company had revenue of $1.21 million for the quarter, compared to analysts’ expectations of $1.13 million. On average, equities analysts predict that Cibus, Inc. will post -2.96 earnings per share for the current year.

Wall Street Analyst Weigh In

CBUS has been the subject of a number of recent research reports. Canaccord Genuity Group cut their price objective on Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd. HC Wainwright reaffirmed a “buy” rating and set a $25.00 target price on shares of Cibus in a report on Friday, March 21st.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.